Copyright
©The Author(s) 2015.
World J Hepatol. Nov 18, 2015; 7(26): 2676-2680
Published online Nov 18, 2015. doi: 10.4254/wjh.v7.i26.2676
Published online Nov 18, 2015. doi: 10.4254/wjh.v7.i26.2676
Table 1 Hepatitis C prevalence rates in developed and developing countries[1]
| Country | Prevalence |
| Egypt | 18%-22% |
| Italy | 2.5%-10% |
| Pakistan | 4.9% |
| China | 3.2% |
| Indonesia | 2.1% |
Table 2 Pretreatment assessments in patients with chronic hepatitis C virus infection[23]
| Medical history, including previous antiviral therapies and response |
| Psychiatric history, including substance use disorders |
| Liver function tests, including liver enzymes, serum albumin, serum bilirubin, and prothrombin time |
| Complete blood count |
| Thyroid-stimulating hormone |
| Serum creatinine |
| Plasma glucose |
| Pregnancy test (in female of childbearing period) |
| HIV serology |
| Hepatitis B surface antigen |
| Quantitative HCV RNA measurement |
| Retinal examination |
| Electrocardiogram |
- Citation: Mohamed AA, Elbedewy TA, El-Serafy M, El-Toukhy N, Ahmed W, Ali El Din Z. Hepatitis C virus: A global view. World J Hepatol 2015; 7(26): 2676-2680
- URL: https://www.wjgnet.com/1948-5182/full/v7/i26/2676.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i26.2676